Ticker: NYT

The New York Times Company

Media Communication Services Publishing

Price 69.81

Reco Hold Potential 59 Risk 57 Updated 2026-10-27

Official website

Forecast impact

neutral

Target +7.4% target fill 93.1%

Reaction D5 -4.17% · D10 -4.53%

Impact Potential 0 · Risk 0 valid until 2026-11-10

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

The New York Times Company operates in the communication services sector, primarily focusing on digital and print media. Its core products include news articles, opinion pieces, and multimedia content, delivered through various platforms such as its website and mobile applications. Major business segments encompass subscription services, advertising, and affiliate revenue. The company generates significant revenue from digital subscriptions, which have seen growth, alongside traditional advertising revenue.

Investment Profile

The investment profile of The New York Times Company is more aligned with balanced investors, given its combination of growth potential through digital subscriptions and a modest dividend yield. The stock exhibits moderate volatility, suggesting a stable investment environment. It may appeal to those seeking a blend of capital appreciation and income generation.

Category: Media Sector: Communication Services Industry: Publishing Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-28

EPS (TTM) — earnings per share for the last 12 months, $: 2.35
Revenue QoQ — quarter-over-quarter revenue growth: -11.2%
EPS surprise: 1.1%
20d volatility: 1.2%
Dividend yield: 1.3%
last ex-date: 2026-04-01

AI recommendation changes

Date	Before	After	Reason
2026-10-22	Sell	Hold	Weak fundamentals and mixed momentum signal caution.
2026-09-25	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-09-16	Sell	Hold	Mixed performance; cautious due to revenue decline.
2026-09-07	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-08-31	Sell	Hold	Weak fundamentals and negative momentum raise concerns.
2026-08-06	Hold	Sell	Weak fundamentals and negative momentum signal high risk.
2026-07-25	Sell	Hold	Weak fundamentals and negative momentum raise concerns.
2026-07-15	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-07-07	Sell	Hold	Mixed performance; cautious outlook amid revenue decline.
2026-06-25	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-06-17	Sell	Hold	Weak fundamentals and mixed momentum signal caution.
2026-06-09	Buy	Sell	Weak fundamentals and negative momentum raise concerns.
2026-05-30	Hold	Buy	Strong revenue growth, but mixed momentum signals.
2026-05-14	Buy	Hold	Weak momentum and high risk offset solid fundamentals.
2026-05-08	—	Buy	Mixed momentum signals; cautious outlook warranted.
2026-05-08	Buy	Buy	Компания показывает стабильный рост выручки и положительную динамику за последние 120 дней, однако недавнее снижение цены акций и низкий дивидендный доход могут указывать на определенные риски.
2026-02-18	—	Buy	Компания показывает устойчивый рост цен на акции за последние месяцы, что свидетельствует о положительном тренде. Учитывая текущие показатели и потенциал дальнейшего роста, рекомендуется покупать.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-11	Morgan Stanley	Target Lowered	90 → 75	66.32
2026-09-15	UBS	Rating Upgraded	— → 82	70.34
2026-09-15	New Street	Rating Upgraded	— → 82	70.34
2026-08-18	UBS	Target Lowered	95 → 75	65.74
2026-08-06	Barclays	Target Lowered	66 → 63	65.48
2026-06-24	UBS	Target Lowered	87 → 80	72.83
2026-05-07	Morgan Stanley	Target Raised	68 → 90	81.47
2026-05-07	Deutsche Bank	Target Raised	75 → 95	83.25
2026-05-07	Evercore ISI	Target Raised	75 → 92	82.26
2026-05-07	Barclays	Target Raised	60 → 66	83.68
2026-02-05	Evercore ISI	Target Raised	69 → 75	68.59
2026-02-04	Guggenheim	Target Raised	— → 63	67.56
2026-01-20	Barclays	Target Raised	55 → 60	71.49
2025-12-18	Morgan Stanley	Target Raised	62 → 68	69.5
2025-11-06	UBS	Target Raised	60 → 69	59.76
2025-11-06	UBS	Target Raised	59 → 62	59.735

News Page 1 of 1

Options Activity Surges in New York Times Company (NYT) Amid Ongoing Lawsuit Over AI Copyright Issues

09/21/2026, 08:37 AM investing review Microsoft The New York Times Company

The ongoing lawsuit involving the New York Times and tech giants Microsoft and OpenAI has significant implications for the future of journalism and intellectual property rights, prompting increased options trading activity in NYT shares as investors speculate on potential outcomes.

Analysts Guggenheim upgraded The New York Times Company (NYT) to Buy with $82 target (upside +20%)

09/15/2026, 05:37 AM investing rating_growth Analysts: analysts, Guggenheim The New York Times Company

Recent analyst calls indicate a positive outlook for several companies, with upgrades and initiations suggesting potential growth in various sectors, particularly in technology and healthcare. Investors should pay attention to these recommendations as they may influence stock performance and market trends.

DOJ Withdraws Subpoenas for New York Times Reporters in Trump Air Force One Investigation

07/23/2026, 12:37 PM politics announcement The New York Times Company

The Department of Justice has withdrawn subpoenas aimed at New York Times reporters regarding their coverage of President Trump's new Air Force One jet, a significant development for press freedom and government transparency.